Changhai Hospital

This study is testing whether adding a new immunotherapy drug (toripalimab) to a standard bladder cancer treatment (BCG) can better control high-risk bladder cancer. The goal is to help patients avoid having their bladder surgically removed. The study will enroll 31 patients to s…

This early-stage study is testing a new type of cell therapy called anti-CD19/BCMA universal CAR-T cells in people with severe autoimmune diseases that have not improved with standard treatments. The main goals are to check if the treatment is safe and to see if it can help contr…

This study is testing a new combination treatment designed to control high-risk bladder cancer while allowing patients to keep their bladder. It combines a precise freezing technique performed during tumor removal with immunotherapy and low-dose chemotherapy. The goal is to see i…

This study is testing if a drug called hetrombopag can safely prevent a dangerous drop in platelets (cells that help blood clot) caused by chemotherapy in people with stomach, colon, or other gastrointestinal cancers. It will enroll 40 patients who are at risk for this side effec…

This is a first-in-human study to test the safety and early effectiveness of a new cell therapy called CAR-NK cells in patients with advanced pancreatic cancer. The study will enroll a small group of patients whose cancer has progressed despite standard treatments. The main goal …

This study is testing whether transplanting healthy gut bacteria from a donor (a fecal microbiota transplant or FMT) can help patients with moderate to severe acute pancreatitis. The goal is to see if this treatment can prevent dangerous late complications like pancreatic infecti…

This study is testing whether a pre-packaged, low-residue diet is as good as standard methods for cleaning the bowel before a colonoscopy in people with inflammatory bowel disease (IBD). Researchers want to see if this special diet can make the preparation process more comfortabl…

This early-stage study is testing a new type of cell therapy called universal CAR-T cells (KN3601) in adults with severe autoimmune kidney diseases that have not responded to standard treatments. The main goals are to check if the treatment is safe and to see if it can help contr…

This early-stage trial is testing a new treatment for advanced pancreatic cancer. Doctors take a patient's own immune cells (T cells), genetically modify them in a lab to recognize and attack cancer cells with a specific KRAS G12V mutation, and then infuse them back into the pati…

This study is testing a new artificial intelligence (AI) system designed to help doctors diagnose and manage pancreatic diseases from CT scans. It will compare the AI's recommendations for surgery or monitoring against the decisions of experienced doctors in 2,000 patients. The m…

This study is testing if a lower dose of a rectal anti-inflammatory drug (indomethacin) works as well as the standard dose to prevent painful pancreas inflammation after an ERCP procedure. Over 1,300 adults scheduled for ERCP will be randomly given either the low or standard dose…

This study aims to understand and improve how patients with Inflammatory Bowel Disease (IBD) prepare their bowels for colonoscopy exams. Researchers will observe 1,000 patients across China to see what factors lead to poor preparation and how well current guidelines are followed.…

This study aims to collect medical images from patients to create a large database. The database will be used to train artificial intelligence (AI) systems to better recognize early signs of cancer in the esophagus and stomach. Researchers are recruiting 500 adults who are alread…